What Amgen said on its Nov 3 earnings call
Kalshi’s markets for this event have closed. We keep its title and words here with our count, never a price.
Kalshi’s markets for this event have closed. We keep its title and words here with our count, never a price.
Q3 2026 earnings call
6 of 14 words said
Our count of the transcript. Kalshi settles.
| Word | Uses | Forms counted |
|---|---|---|
| Said · 6 | ||
| Dazodalibepdazodalibep 9 | 9 | dazodalibep 9 |
| Eosinophiliceosinophilic 6 | 6 | eosinophilic 6 |
| ESMOESMO 5 | 5 | ESMO 5 |
| Imfinzi / DurvalumabIMFINZI 5 | 5 | IMFINZI 5 |
| GLP-1 / GLPGLP-1 3 · GLP-1s 1 | 4 | GLP-1 3 · GLP-1s 1 |
| MedicareMedicare 1 | 1 | Medicare 1 |
| Said, under the threshold · 2 | ||
| Artificial Intelligence3+×artificial intelligence 1 · needs 3 | 1 | artificial intelligence 1 · needs 3 |
| Oral3+×orals 1 · needs 3 | 1 | orals 1 · needs 3 |
| Not said · 6 | ||
| Acquisition · Buyback / Buy Back · Litigation · Patent2+× · Prolia2+× · Tavneos | ||
Counted by the market’s rules. How we count → · A count looks wrong? Report it (email) · Powered by Kalshi Research (opens in a new tab)
Amgen said 12 of the 14 words on this board at least once in the 5 calls before Nov 3. Said most often: GLP-1 / GLP (4 of 5), Eosinophilic (4 of 5) and Oral3+× (3 of 5). Not said in any of them: Buyback / Buy Back and Imfinzi / Durvalumab.
5 calls counted before Nov 3 · Aug 2025 – Aug 2026
Pro counts the last 15 calls, 10 more than shown. $19 a month for 12 months if you start by Tue Dec 1. See plans
Market words from Kalshi · Powered by Kalshi Research (opens in a new tab) · Closed markets show no prices.
“Said” counts appearances where the word qualified under the market’s rules (exact word or phrase, plural or possessive, any slash alternative; a hyphenated form, like pro-Trump for Trump; a 3+× chip means that many uses in one appearance). Full counting rules →
A count looks wrong? Use Report on its row to email us.